The eradication rates by per-protocol analysis were 68.5 % ( 95 % CI : 59.6-77 .4 ; 74 of 108 patients ) , 78.4 % ( 95 % CI : 70.3-86 .5 ; 80 of 102 patients ) , and 89.5 % ( 95 % CI : 83.2-95 .8 ; 85 of 95 patients ) in the 7-day PPI triple , 10-day and 15-day sequential therapy groups , respectively ( p = 0.001 ) .